China tuberculosis diagnosis and treatment market is anticipated to grow at a CAGR around 3.1% during the forecast period. China being the largest populated country has the world’s second largest burden of multidrug-resistant tuberculosis. Government initiatives play an important role in market growth as they are responsible for large adoption of tuberculosis diagnosis and treatment. China launched the 10 year Infectious and Endemic Disease Control (IEDC) project in 1991 to curb the TB epidemic in 13 of its 31 mainland provinces. It was funded by a World Bank loan of $58 million and this project adopted the TB DOTS strategy as well as short course drug treatment developed by the World Health Organization (WHO) in 1989. The project set out to improve the finding of new smear positive cases from 35% to 70%.
Get Free Sample link @ https://www.omrglobal.com/request-sample/china-tuberculosis-diagnosis-treatment-market
China tuberculosis diagnosis and treatment market is segmented on the basis of drugs type and diagnosis. Based on drug type, the market is segmented into first line drugs and second line drugs. Based on diagnosis, the market is segmented into laboratory testing, nucleic acid amplification test, mantoux test, radiography and drug susceptibility testing.
A full report of China Tuberculosis Diagnosis and Treatment Market available @ https://www.omrglobal.com/industry-reports/china-tuberculosis-diagnosis-treatment-market
- Market Coverage
- Market number available for – 2019-2025
- Base year- 2019
- Forecast period- 2020-2025
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
China Tuberculosis Diagnosis and Treatment Market by Drugs Type
- First Line Drugs
- Second Line Drugs
China Tuberculosis Diagnosis and Treatment Market by Diagnosis
- Laboratory Testing
- Nucleic Acid Amplification Test
- Mantoux Test
- Radiography
- Drug Susceptibility Testing
Company Profiles
- Abbott Laboratories
- Becton, Dickinson and Co.
- Biochemical and Synthetic Products Pvt Ltd.
- Eiken Chemical Co., Ltd.
- Hoffmann-La Roche Ltd.
- GlaxoSmithKline PLC
- Labatec Pharma SA
- Lupin Pharmaceuticals, Inc.
- Thermo Fisher Scientific
The Report Covers
- Comprehensive research methodology of the China Tuberculosis Diagnosis and Treatment market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the China Tuberculosis Diagnosis and Treatment market.
- Insights about market determinants which are stimulating the China Tuberculosis Diagnosis and Treatment market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/china-tuberculosis-diagnosis-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
